Vancouver, BC, CA
Small Business (1-10M TTM Revenue)
Kairos Therapeutics is developing a pipeline of antibody-drug conjugate (ADC) therapeutics for the treatment of various forms of cancer. The technology was developed in-house at The Centre for Drug Research and Development (CDRD) and has been exclusively licensed to Kairos from CDRD through its commercialization vehicle, CDRD Ventures Inc.
|Kairos Therapeutics Vancouver, BC, V6T 1Z3 Canada|
To request access, simply fill out the form below and we will contact you.